Adaptive Phage gets $10M from DoD for antibacterial phage therapies
The company is developing phage-based therapies designed to target specific bacteria strains, as contrasted with antibiotics, which target multiple types of bacteria.
FDA approves new triple-drug antibiotic from Merck
Recarbrio was approved for treating complex urinary tract and intra-abdominal infections among adult patients who have limited or no therapy options.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The Medicines Co. spin-out Qpex launches with $33M in VC funding for antibiotics development
With New Enterprise Associates at the helm of the round, the company is setting out to develop antibiotics for drug-resistant bacterial infections.
Start-up plans to target epilepsy using gut microbiota
Bloom Science plans to have its proprietary gut bacteria in the clinic for hard-to-treat patients in the next 12-18 months.
CDC found over 220 cases of “nightmare bacteria” last year
Dr. Anne Schuchat, the CDC's principal deputy director, said she was surprised by the extent of the spread of the bacteria, which are virtually untreatable and capable of spreading genes that make them impervious to most antibiotics.
Axial Biotherapeutics raises $19.15M to target gut-brain axis
Axial Biotherapeutics is the latest startup working to manipulate the microbiome as a means to treat disease. The Caltech spin-out just announced $19.15 million in Series A funding to tackle a range of central nervous system disorders.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Synlogic raises $40M for “designer probiotics”
The company is engineering microbes to treat irritable bowel syndrome, PKU and other disorders.
The best way to protect your kids from allergies: Let them play in the dirt
Microbiologist Jason Tetro explains that the best way to protect your child against allergies is to let them get dirty.
Is it a virus or a bacteria? New test may help curb unnecessary antibiotic prescription
A team of Israeli researchers have developed a test that can distinguish whether an infection stems from a virus or a bacteria – a simple but potentially impactful screener that could cut down unnecessary use of antibiotics. Hailing from Israel-based biotech MeMed, the overarching goal is to curb antibiotic resistance – which is growing thanks […]
Some New Yorkers live near a cheese-coated subway station. Others, traces of meningitis
In the first genetic profile of a metropolitan transit system, Weill Cornell Medical College researcher Christopher Mason and his team spent 18 months swabbing 466 subway stations in New York City. The findings were published in the journal Cell Systems. He says in many ways the results are “a mirror of the people themselves who ride […]
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Don’t panic about viruses and bacteria, just knit them
Entries are flooding in for #KnitABug competition, here’s #Ecoli – Last days to enter! http://t.co/87t8HiLH2S @UKHKA pic.twitter.com/amD9iO3XgL — BBSRC (@BBSRC) October 22, 2014 Those who happen to be super into bacteria and viruses and also have a knack for knitting were in luck this year. In conjunction with the Great British Bioscience Festival, BBSRC put together Knit-a-Bug: The Great […]